Trial Profile
Evaluation of Post Hospital Administration of Celecoxib Following Minimally Invasive Knee Replacement Surgery: A Randomized Controlled Study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary)
- Indications Perioperative pain; Postoperative pain
- Focus Therapeutic Use
- 26 Apr 2016 Status changed from active, no longer recruiting to completed.
- 01 Sep 2011 Results published in the Journal of Arthroplasty.
- 14 Apr 2009 Actual patient number (107) added as reported by ClinicalTrials.gov.